Published in Support Care Cancer on March 09, 2012
Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009. BMC Cancer (2015) 1.41
The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients. Support Care Cancer (2013) 1.05
Why pediatric patients with cancer visit the emergency department: United States, 2006-2010. Pediatr Blood Cancer (2014) 0.92
Protocol for a systematic review of reductions in therapy for children with low-risk febrile neutropenia. Syst Rev (2014) 0.79
A retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemia. Cancer Med (2015) 0.77
Systematic review of reduced therapy regimens for children with low risk febrile neutropenia. Support Care Cancer (2016) 0.77
Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis. Br J Cancer (2016) 0.76
The influence of different fever definitions on the rate of fever in neutropenia diagnosed in children with cancer. PLoS One (2015) 0.75
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol (2008) 14.36
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis (2011) 9.37
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med (1966) 7.30
Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med (2006) 5.61
Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med (1993) 4.12
Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med (1971) 3.82
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol (2000) 3.69
What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol (2000) 3.37
A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med (1999) 3.02
Outpatient management of febrile neutropenia: time to revise the present treatment strategy. J Support Oncol (2008) 2.12
Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol (2010) 1.81
Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. Med Pediatr Oncol (2000) 1.72
A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia. J Pediatr (1996) 1.66
Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol (2005) 1.62
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Cochrane Database Syst Rev (2004) 1.59
Oral vs. intravenous empirical antimicrobial therapy in febrile neutropenic patients receiving childhood cancer chemotherapy. J Pediatr (Rio J) (2009) 1.46
A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol (2006) 1.11
Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis. Ann Oncol (2011) 1.11
Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study. Pediatr Blood Cancer (2007) 1.08
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer (1999) 1.08
Nosocomial infections in patients with cancer. Lancet Oncol (2009) 1.05
Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer. Pediatrics (2011) 1.03
Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres. Arch Dis Child (2007) 1.01
Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection. J Clin Oncol (2004) 0.99
Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences. J Clin Oncol (2004) 0.98
Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people. Eur J Cancer (2010) 0.97
Agreement between children with cancer and their parents in reporting the child's health-related quality of life during a stay at the hospital and at home. Child Care Health Dev (2009) 0.93
Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer. Pediatr Blood Cancer (2010) 0.93
Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropenia. Pediatr Blood Cancer (2007) 0.90
Management of febrile neutropenia in pediatric oncology patients: a Canadian survey. Pediatr Blood Cancer (2007) 0.90
Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia. J Pediatr Hematol Oncol (2009) 0.87
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. Cancer (2001) 0.87
Low risk episodes of fever and neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the new gold standard of care? Pediatr Blood Cancer (2005) 0.84
Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer (2000) 0.83
Out-patient management of febrile neutropenia in indigent paediatric patients. Ann Acad Med Singapore (1997) 0.80
Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours. Pediatr Blood Cancer (2004) 0.78
Prospective audit of treatment of paediatric febrile neutropenia in Australasia. J Paediatr Child Health (2005) 0.77
Ambulatory treatment with ceftriaxone in febrile neutropenic children. Isr J Med Sci (1994) 0.77
Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors. Turk J Pediatr (2001) 0.76
Ceftriaxone as a single agent in empirical therapy of unexplained fever in granulocytopenic children with solid tumors. J Chemother (1997) 0.75
Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med (2000) 9.36
Quantification of sleepiness: a new approach. Psychophysiology (1973) 6.36
Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol (2001) 4.48
Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother (2005) 3.81
Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis (2001) 3.68
CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol (2000) 3.36
Cardiac catheterisation by the Judkins technique as an outpatient procedure. BMJ (1989) 2.92
The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med (1999) 2.76
Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut (2008) 2.65
Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. J Biol Chem (1998) 2.32
The role of glutamate dehydrogenase in plant nitrogen metabolism. Plant Physiol (1991) 2.15
Serum resistance among Escherichia coli strains causing urinary tract infection in relation to O type and the carriage of hemolysin, colicin, and antibiotic resistance determinants. Infect Immun (1982) 2.12
[Recurrence of unipolar depression and efficacy of maprotiline]. Encephale (1990) 2.04
Testing process errors and their harms and consequences reported from family medicine practices: a study of the American Academy of Family Physicians National Research Network. Qual Saf Health Care (2008) 1.98
Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B. Mol Cell Biol (1996) 1.91
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81
Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum Mol Genet (1999) 1.79
Posaconazole salvage treatment in paediatric patients: a multicentre survey. Eur J Clin Microbiol Infect Dis (2010) 1.60
Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest (1998) 1.58
Predicting the outcome of neonatal bacterial meningitis. Pediatrics (2000) 1.56
Violence and injury mortality in the Cape Town metropole. S Afr Med J (1997) 1.55
Altered gastric emptying in the head-injured patient: relationship to feeding intolerance. J Neurosurg (1991) 1.55
Labial fat pad grafts (modified Martius graft) in complex perianal fistulas. Ann R Coll Surg Engl (1998) 1.54
Multiorgan dysfunction in infants with post-asphyxial hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed (2004) 1.53
Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca(2+) stabilization. EMBO J (2001) 1.52
Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation. J Immunol Methods (2004) 1.49
Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J Lab Clin Med (1991) 1.49
Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol Rev (1997) 1.49
Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science (1995) 1.48
Preventing dog bites in children: randomised controlled trial of an educational intervention. BMJ (2000) 1.47
Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome. Cancer Res (1997) 1.47
A method of reconstructing a natural-looking umbilicus in abdominoplasty. Ann Plast Surg (1997) 1.47
A cluster randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of classroom-based cognitive-behavioural therapy (CBT) in reducing symptoms of depression in high-risk adolescents. Health Technol Assess (2013) 1.46
Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens. Bone Marrow Transplant (2006) 1.46
An outreach education and treatment project in Ghana for the early stage of Mycobacterium ulcerans disease. Trans R Soc Trop Med Hyg (2003) 1.44
Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Int J Colorectal Dis (2005) 1.42
Quality of randomized clinical trials in juvenile idiopathic arthritis. Rheumatology (Oxford) (2008) 1.40
Acid-base status in fetal heart blood in erythroblastotic fetuses: a study with special reference to the effect of transfusions with adult blood. Am J Obstet Gynecol (1989) 1.39
Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J Pathol (2007) 1.38
A comparative trial of the antidepressant, anxiolytic, and cardiovascular effects of trimipramine and doxepin in depressed hospitalized patients. J Clin Psychiatry (1985) 1.38
Platelet size in myocardial infarction. Br Med J (Clin Res Ed) (1983) 1.38
How can paediatric epilepsy services best be delivered in secondary care? Seizure (2004) 1.38
Exercise after myocardial infarction: a controlled trial. J R Coll Physicians Lond (1982) 1.37
Resting energy expenditure in patients with alcoholic hepatitis. JPEN J Parenter Enteral Nutr (1989) 1.36
The South African National Non-Natural Mortality Surveillance System--rationale, pilot results and evaluation. S Afr Med J (2001) 1.34
High mean platelet volume after myocardial infarction: is it due to consumption of small platelets? Br Med J (Clin Res Ed) (1984) 1.30
Effect of whole-body vibration on BMD: a systematic review and meta-analysis. Osteoporos Int (2010) 1.29
Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. J Med Genet (1998) 1.27
Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. Hum Mol Genet (1998) 1.26
Preoperative urography in large bowel cancer: a useless investigation? Br J Surg (1983) 1.26
Masticatory loading and bone adaptation in the supraorbital torus of developing macaques. Am J Phys Anthropol (2009) 1.23
Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group. Pharmacoepidemiol Drug Saf (2012) 1.20
Hypertension and renal failure in Kumasi, Ghana. J Hum Hypertens (1999) 1.18
Differentiating salmon populations at broad and fine geographical scales with microsatellites and single nucleotide polymorphisms. Mol Ecol (2008) 1.16
Bacteria causing symptomatic urinary tract infection or asymptomatic bacteriuria. J Clin Pathol (1979) 1.14
Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Leukemia (2011) 1.13
Prognosis-based futility guidelines: does anyone win? SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc (1994) 1.13
Quantitative shedding of two genotypes of Cryptosporidium parvum in California ground squirrels (Spermophilus beecheyi). Appl Environ Microbiol (2001) 1.12
Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J Immunol (1995) 1.12
Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer (2000) 1.11
A new pendant storage oxygen-conserving nasal cannula. Chest (1985) 1.11
Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis. Ann Oncol (2011) 1.11
Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus. Antimicrob Agents Chemother (1991) 1.09
Do advance directives save resources? Clin Res (1993) 1.09
Regulation of glutamate dehydrogenase activity in relation to carbon limitation and protein catabolism in carrot cell suspension cultures. Plant Physiol (1992) 1.09
Teaching invasive perinatal procedures: assessment of a high fidelity simulator-based curriculum. Ultrasound Obstet Gynecol (2002) 1.08
Analysis of a hospital-based stomatherapy service. Ann R Coll Surg Engl (1985) 1.07
Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome. Gut (1999) 1.06
Video capsule endoscopy in peutz-jeghers syndrome: a blinded comparison with barium follow-through for detection of small-bowel polyps. Endoscopy (2006) 1.06
Pharmacotherapy for people with Alzheimer's disease: a Markov-cycle evaluation of five years' therapy using donepezil. Int J Geriatr Psychiatry (1998) 1.06
Explaining differences in the severity of familial adenomatous polyposis and the search for modifier genes. Gut (2001) 1.05
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood (2000) 1.05
Dynamic MR imaging compared with evacuation proctography when evaluating anorectal configuration and pelvic floor movement. AJR Am J Roentgenol (1997) 1.04
Thermodynamic data for the secondary phosphate ionizations of adenosine, guanosine, inosine, cytidine, and uridine nucleotides and triphosphate. J Biol Chem (1965) 1.04
Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. J Clin Endocrinol Metab (1994) 1.03
Isolation of an Escherichia coil strain mutant unable to form biofilm on polystyrene and to adhere to human pneumocyte cells: involvement of tryptophanase. Can J Microbiol (2002) 1.02
The psychological impact on staff of caring for people with serious diseases: the case of HIV infection and oncology. J Psychosom Res (1996) 1.02
Identification of a novel HLA-A25-restricted epitope in a conserved region of p24 gag (positions 71-80). AIDS (1996) 1.01
Symptom management and self-care for peripheral neuropathy in HIV/AIDS. AIDS Care (2007) 1.01
Course of patients discharged early after myocardial infarction. Br Med J (1976) 1.01
Cellular protection mechanisms against extracellular heme. heme-hemopexin, but not free heme, activates the N-terminal c-jun kinase. J Biol Chem (1999) 1.00
Pediatric environmental health training. Impact on pediatric residents. Am J Dis Child (1993) 1.00
Photodynamic therapy for polyps in familial adenomatous polyposis--a pilot study. Eur J Cancer (1995) 1.00
Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. J Viral Hepat (2001) 0.99
Do hyperoxaemia and hypocapnia add to the risk of brain injury after intrapartum asphyxia? Arch Dis Child Fetal Neonatal Ed (2005) 0.99
Comparative analysis of Shwachman-Diamond syndrome to other inherited bone marrow failure syndromes and genotype-phenotype correlation. Clin Genet (2011) 0.99
The Distribution of Sympathetic Fibres in the Extremities. J Anat (1932) 0.98
Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation. Gut (2006) 0.98
Site-directed mutagenesis reveals the importance of disulfide bridges and aromatic residues for structure and proliferative activity of human interleukin-4. FEBS Lett (1991) 0.97
DNA synthesis, cell division and specific cytodifferentiation in cultured pea root cortical explants. Dev Biol (1973) 0.97
Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot study. Br J Haematol (2001) 0.96
Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy. Bone Marrow Transplant (2008) 0.96
Seventh-Day Adventist vegetarians have a quiescent proliferative activity in colonic mucosa. Cancer Lett (1985) 0.96
A self-correcting indirect calorimeter system for the measurement of energy balance in small animals. J Appl Physiol (1985) (2001) 0.96
Macrosomia prediction using ultrasound fetal abdominal circumference of 35 centimeters or more. Obstet Gynecol (1999) 0.96
Discharge planning: comparison of patients and nurses' perceptions of patients following hospital discharge. Image J Nurs Sch (1996) 0.96
Time for paediatric febrile neutropenia guidelines - children are not little adults. Eur J Cancer (2011) 0.95